DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Oddens J, Brausi M, Sylvester R. , et al.
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.
Eur Urol 2013;
63 (03) 462-472
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.